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Present evidence suggests that the process of neoplastic transformation can 
be initiated by direct structural alterations of the genetic material of target 
cells. Correspondingly, there is a strong correlation between oncogenicity and 
mutagenicity for almost all carcinogens tested (McCann et a1. 1975; Monte-
sano et ar. 1976). Covalent binding to DNA has been shown for the elec-
trophilic, ultimate metabolic derivatives of a large number of chemical car-
cinogens (Miller and Miller 1974). Many aromatic carcinogens are, in 
addition, capable of stacking interactions with DNA (Ames et al. 1972). 
On the other hand, extensive studies on both the metabolic activation of 
oncogenic agents (Magee 1974) and the physical chemistry of their primary 
interactions with cellular constituents have thus far failed to establish a 
specific, common type of "oncogenic" reaction at the molecular level (Heidel-
berger 1975). Instead, it appears that a variety of initial molecular alterations 
caused by different types of carcinogenic agents may share the property of in-
creasing the probability for expression of a "neoplastic phenotype." 
The probability of neoplastic transfonnation, however, is unlikely to be a 
simple function of the type and degree of primary carcinogen-cell interaction. 
Specific phenotypic properties of the target cells at the time of exposure to a 
carcinogen, i.e., their state of differentiation and proliferation, may be 
equally important determinants (Rajewsky 1972; Goth and Rajewsky 
1974a,b; Rajcwsky et a1. 1976). Particularly relevant in this context are 
the rate of target-cell proliferation, since repeated rounds of DNA replication 
and cell division seem to be required (or the "fixation" of carcinogen-induced 
genome alterations (Sachs 1966; Rajewsky 1967, 1972; Kakunaga 1974), 
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and the capacity of target cells to eliminate and replace (repair) carcinogen-
modified, potentially mutagenic molecular structures in DNA (see Roberts et 
a!. 1968; Cleaver 1973; Goth and Rajewsky 1974a,b; van Lancker 1974; 
Cleaver and Boorsma 1975) . This requires characterization of the state of 
differentiation and functional behavior of the target cells and possibly an 
analysis of subpopulations of "high-risk" cells contained in the target tissues 
with their usually complex cellular composition. 
A lead in the search for cellular detenninants favoring neoplastic trans-
form ation may be provided by the pronounced tissue specificity of the on-
cogenic effect of certain carcinogens which do not require enzymatic meta-
bolic activation, Le., in cases where this specificity cannot be due to tissue 
differences in the activity of enzymes involved in the formation of the ultimate 
reactants (Goth and Rajewsky 1974a,b). A carcinogen that fulfills this con-
dition is the ethylating agent N-ethyl-N-nitrosourea (EtNU) (Ivankovic and 
Druckrey 1968). Alkylation of nucleic acid constituents by N-nitroso com-
pounds in relation to mutagenesis and carcinogenesis has received con-
siderable attention recently (see Druckrey et al. 1967; Lawlcy 1974; Singer 
1975) . 
Nervous-system-specific Carclnogenlclly of EtNU In the Rat 
Under in vivo conditions, EtNU undergoes nonenzymatic, heterolytic de-
composition with a half-Ji[e of I" "" 8 minutes (Goth and Rajewsky 1972) . 
The ultimate reactant, an ethyl cation, is thus produced indiscriminately in 
al1 tissues. In spite of this, a single pulse of EtNU applied to rats during the 
perinatal age specifically results in a very high incidence o[ neuroectodermal 
neoplasms in the central and peripheral nervous systems (NS) (lvankovic 
and Druckrey 1968; Wechsler et a!. 1969) after a strain-dependent (Druckrey 
et aI. 1970a) and dose-dependent "latency time" (Table I) (Goth and Rajew-
sky 1974a,b; Laerum and Rajewsky 1975). During the prenatal and early 
postnatal age period, when the tumorigenic effect of EtNU is maximal, the 
developing rat NS contains highly proliferative matrices, e.g., the subependy-
mal area of the brain (Altman 1969; Bosch et a!. 1972; Goth and Rajewsky 
1974a,b) . With increasing age and maturation o[ the NS, the sensitivity 
towards EtNU subsides drastically (Druckrey et a!. 1970b; see Table I and 
Fig. I). This indicates that the carcinogenic effect also depends on the 
presence at the time of the carcinogen pulse of (precursor type) target cells 
with particular proliferative and/ or differentiative properties (Goth and 
Rajewsky 1974a,b). The spectrum o[ neuroectodennal rat tumors induced 
by EtNU encompasses mixed glioma-, astrocytoma·, oligodendroglioma-, 
glioblastoma-, and ependymoma-like neoplasms in the brain and neurinoma-
or Schwannoma-like tumors in the peripheral NS (Ivankovic and Druckrey 
1968; Wechsler et a!. 1969; Laerum and Rajewsky 1975; Swenberg et a!. 
1975). 
Initial Degree of DNA Ethylalion by EINU 
The initial extent of base ethylation in DNA would be expected to be of 
similar magnitude in both "high-risk" and '''low-risk'' tissues due to their 
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Mortality with neuroectodermal tumors in the offspring of BD IX rats 
exposed transplacentally 10 a single dose of 75 p.g of EtNU/ g body weight 
administered to pregnant females by i.v. injection on the 18th day of gestation 
(grollp /) and in BD IX rats treated i.p . with the same dose of EINU at the 
age of 10 days (group 2). Each point represents one animal. Note the normal 
distribution of limes until death with tumors. Horizontal lines (probits) 
indicate one standard deviation of the T~o values. Y is the percentage of 
animals with macroscopically detectable neoplasms. T:iD is the median time 
until death with neuroectodermal neoplasia (ct. Table 1). Group J: Y = 
89% , T f10 = 195 days ::t: 8% (S.D.); group 2: Y = 95%. Teio = 291 days ::t: 
22% (S.D.). 
equal exposure to the EtNU-derived ethyl cation. This was tested by intra-
venous (i.v.). transplacental (t.p.), or intraperitoneal (Lp.) application of 
[1-HClEtNU (sp. act. = 5.7 Ci/ mole; Farbwerke Hoechst AG, Frankfurt/ 
Main, Germany) to fetal (18th day of gestation), IO-day-old, and adult rats 
of the BD IX strain, as well as to IO-day-old rats of the BD IV strain, respec-
tively. The genotypes and phenotypes of the inbred BD strains have been 
described elsewhere (Druckrey 1971) . DNA was isolated from brain, liver, 
and other pooled tissues with a modified Kirby method (Goth and Rajewsky 
1974a,b). After mild hydrolysis of DNA in 0.1 N HCI at 37°C for 20 hours 
(Lawley and Thatcher 1970) and addition of nonradioactive ethylated purine 
bases as markers, radiochromatography was carried out on Sephadex G-IO 
(Fig. 2) with 0.05 M ammonium formate buffer, pH 6.8 (Lawley and Shah 
1972). The molar fractions of ethylated bases were calculated from the in-
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Separation of bases from brain DNA by rad iochromatography on Sephadex G-IO 
at 4 hr after ethyJation in vivo by an i.p. pulse of 75 fig of [l .uC]EtNU/g to 10-
day-old BD IX rats. Nonradioactive N3_EtG, NT_EtG, and OB-EtG were added as 
markers. (Reprinted, with permission. from Goth and Rajewsky 1974a.) 
tegral I·C-activity of the corresponding chromatographic peaks, considering 
their specific UC-activity as identical with that of the [l-HC]EtNU used. The 
amounts of guanine (G) and adenine (A) were derived from the ultraviolet 
(UV)-extinction values of the respective peaks and based on molar extinc-
tion coefficients, at neutral pH, of £260 = 7200 for G and £260 = 13,300 for A 
(ChargafI and Davidson 1955). 
As expecled, Ihe initial (1 hr after injection of 75 "g of [l-HC]EINU/ g) 
molar fraclions of NT-elhylguanine (NT-EIG/G), O' -elhylguanine (O'-EIGI 
G) , and N'-elhyladenine (N' -EtA/A) in Ihe DNA of high-risk (felal and 
IO-day-old brain) and low-risk (liver and adult brain) tissues were found to 
be similar (-1-2 X 10- ') (Golh and Rajewsky 1974a,b). The relative 
initial frequencies of these ethylation products in DNA were -55% (NT. 
EIG), -28% (O'-EIG), and -17% (N'-EIA), respeclively. Similar rela-
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tive values were obtained after incubation of rat liver DNA with [1-UClEtNU 
for 1 hour at 37'C in 25 mM potassium phosphate buffer, pH 7.2 (Goth and 
Rajewsky I 974b). Therefore, the initial degrce of purine base ethylation in 
DNA per se does not explain the NS specificity of the carcinogenic effect. 
Only 20-30% of thc total HC-activity in the Sephadex G-IO radiochro-
f h .. HC matograms was due to ethylated purine bases. Most ate remamlng ·ac-
tivity eluted immediately after the void volume (Fig. 2). This "carly peak" 
includes ethylated pyrimidine nucleotides. However, its main component is 
probably phosphotriesters formed by reaction of the EtNU-derived ethyl 
cation with the phosphodiester groups of DNA (Rhaese and Freese 1969; 
Bannon and Vcrly 1972; Goth and Rajewsky 1974b; Sun and Singer 1975) . 
Phosphotriesters are relatively stable in DNA (O'Connor et al. 1973). Their 
presence could lead to alterations of molecular interactions (Miller et a1. 
1974), possibly including a reduced susceptibility of DNA to enzymatic 
hydrolysis. The possible importance of phosphotriesters as promutagenic and 
potentially carcinogenic structural DNA modifications has recently been 
stressed (Singer 1975; Sun and Singer 1975). 
Elhylatlon 01 Guanlne-O' in DNA 
The above analyses have shown that the extranuclear oxygen-6 atom of gua-
nine in DNA is a major site of ethylation by EtNU. Among the various base 
substitutions in DNA, OO-alkylguanine in particular represents a promutagenic 
and thus potentially carcinogenic alteration because of its high probability of 
miscoding and anomalous base·pairing during subsequent DNA replication 
(Loveless 1969; Gerchman and Ludlum 1973). Formation of OO-alkylgua-
niDe in DNA after in vivo administration of alkylating N-nitroso carcinogens 
has been reported by a number of authors over the last several years (Lawley 
and Thatcher 1970; Frei 1971; Craddock 1973; Kleihues and Magee 1973; 
O'Connor et al. 1973; Goth and Rajewsky 1974a,b; Kleihues and Margison 
1974; Magee et al. 1975 ; Margison and K1eihues 1975 ; Nicoll et al. 1975). 
The relative ability of the members of this class of carcinogens to alkylate 
the 0 0 of guanine in DNA increases with their reactivity according to Ingold's 
S, I mechanism (Ingold 1953) and shows a positive correlation with their 
tumorigenicity (Goth and Rajewsky 1974b; Lawley 1974). For example, the 
relative yield of QS·EtG obtained in the present analyses was about four times 
higher than the corresponding O'-methylguanine value reported for the less 
carcinogenic (Druckrey et aI. 1973) methylating homolog of EtNU, N-methyl-
N-nitrosourea (MeNU) (K1eihues and Magee 1973). 
No significant changes were observed in the molar fractions of NT-EtG/ G, 
O' -EtG/ G, and W-EtA/ A in fetal DNA when the EtNU pulse was adminis-
tered during temporary reduction of the rate of DNA replication to -I % 
of the control value by hydroxyurea (500 ~g/g body wI., injected I hr 
prior to the EtNU pulse) (Goth and Rajewsky 1974b) . Similarly, the degree 
of base ethylation in DNA was of the same magnitude in fetal or 10·day-
old vs. adult rat tissues and in liver DNA when the EtNU pulse was placed 
into the "prereplicative phase" (at II hr) vs. the phase of maximum DNA 
replication (at 24 hr) after partial hepatectomy (Goth and Rajewsky 
1974b) . Correspondingly, the median times (Too) until death with ncuro-
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ectodermal neoplasms and the tumor incidence were not significantly changed 
when EtNU was administered to fetal or lO-day-old BD IX rats during 
temporary inhibition of DNA synthesis by hydroxyurea (Table 1) (Goth 
and Rajewsky 1974b). This indicates that OO-cthylation of guanine in DNA 
is not restricted to a situation where the extranuclear oxygen atom is "un_ 
protected" by hydrogen bonding (i.e., replicating DNA). 
Elimination of Elhylaled Purine Bases from DNA (Repair) 
CeHular repair processes for structurally modified DNA involve the elimina-
tion of altered bases from DNA. The rate of elimination from DNA of pro-
mutagenic alkyIated bases such as OB-alkylguanine must influence, for ex-
ample, the frequency of GC-AT transition mutations during DNA replication. 
Elimination rates could, in principle, vary for different tissues, different cell 
types within a given tissue, and different states of differentiation and pro-
liferation of a particular cell lineage. They could therefore represent an im-
portant factor in determining the tissue or cell specificity of the carcinogenic 
effect. Therefore, measurements of the elimination rates of N7-EtG, OB-EtG, 
and N3-EtA from the DNA of different tissues of 10-day-old BD IX rats 
were performed over a period of 240 hours following the EtNU pulse (Goth 
and Rajewsky 1974a,b). These analyses revealed one remarkable difference 
between brain on the one hand and liver and a number of other low-risk 
tissues on the other. OB-EtG disappeared from brain DNA very much more 
slowly (I" - 229 hr) than from liver DNA (I" - 26 hr; see Table 2) or 
from the DNA of several other pooled tissues (kidney, lung, spleen, intestine, 
muscle; t% ,-.. 54 hr) and also more slowly than W-EtG and N3_EtA whose 
respective half-lives were similar in brain and liver DNA (Table 2; Figs. 3 and 
4). Equally similar for brain and liver DNA were the half-lives (I" - 115 
Table 2 
Approximate Half-lives (1 1,4 ) of Ethylated Purine Bases in the DNA of Different 
Tissues after an i.p. Pulse of [1-t4 C1EtNU to lO-Day~old BD IX Rats 
EUmina- Hal/-/ife t% (hr) 
lion 
Tissue kinetics N3~EIA NT-ErG OB-EIG 
Brain in vivo 16' 89' 229b 
liver in vivo 12' 64' 26' 
Other tissues (pooled) in vivo not measured 60' 54' 
DNA ethyJated in vivo in vitroe 33' 225' stable' 
t values obtained for EtNU-ethylated DNA incubated in vitro are given for com-par~on (Goth and Rajewsky 1974a,b; L. Ya. Lomakina and M. F. Rajewsky, unpubl.). 
a Time interval analyzed: 1-25 hr after [I-14CJEtNU pulse. 
b Time interval analyzed: 25-240 hr after [t-14CJEINU pUlse. 
e! Time interval analyzed: 25- 75 hr after [1-HC)EtNU pulse. I%, values for 1-25-hr 
and 7S-114-hr time intervals: 10 hr and 49 hI', respectively. 
d Based on ~easurements at 1, 4. and 240 hr after (f-I4C1EtNU pulse. 
e 2S mM potassium phosphate buffer (0.02%. so~lium a.ride), t;'H 7.2, 37 GC. 
f Time interval analyzed: 1-240 br after begmnmg of IDcubatlon. 
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Kinetics of the elimination of QO-EtG from DNA of brain and liver of lO-day-old 
BD IX and SO IV rats. Molar fractions of OG-EtG/G in DNA of brain and liver 
are given as a function of time after an i.p. pulse of 751!g of {l.HCIEtNU/g. 
Values for DNA isolated from pooled tissues at 4 hr after a (l·HCIEtNU pulse in 
vivo and incubated in 25 mM potassium phosphate buffer, 0.02% sodium azide, pH 
7.2, at 37°C for 240 hr in vitro are given for comparison (Goth and Rajewsky 
1974a,b; L. Ya. Lomakina and M. F. Rajewsky. unpubl.). (0, .) Brain, BD IX 
rat; (.0., .A.) liver, SO IX rat; (+) brain, BD IV rat; (a) DNA incubated in vitro. 
hr and - 99 hr, respectively) of the integral "e-activity of the "early peaks" 
(mainly attributed to ethylphosphotriesters (Goth and Rajewsky 1974b; 
Singer 1975; Sun and Singer 1975) in the Sephadex G-IO radiochromato-
grams (Fig. 4). For comparison, incubation at 37'C for 240 hours of DNA 
previously ethylated by EtNU in vivo showed complete stability of O'=EtG 
in DNA, whereas the in vitro half-lives of N'-EtG and N'-EtA in DNA were 
- 225 hours and - 33 hours, respectively (Table 2; Fig. 3) (Goth and 
Rajewsky 1974b). The observed selective persistence of O'-EtG in brain 
DNA, together with the high rate of DNA replication and cell division in the 
developing NS of the rat, could be responsible for an increased probability 
of malignant transformation in this tissue and could thus provide an explana-
tion for the NS specificity of the carcinogenic effect of EtNU. 
Application of a pulse of 75 ~g of EtNU/g to the fetal or newborn rat 
causes a temporary reduction of DNA synthesis in the NS (Goth and 
Rajewsky 1974b; Bosch and Ebels 1976), probably accompanied by a re-
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FIgure 4 
Brain-la-liver ratio for the molar contents in DNA of 0 6-EtO (0, e) and N7. 
EtG (0, - ), respectively, and for the specific He-radioactivity (dpm/mg 
input DNA) of the "early peak" in the Sephadcx 0-10 radiochromatograms 
(6) (R. Goth and M. F . Rajewsky. unpub!.) as a function of time after an 
i. p. pulse of 75 I!g of [l_14C]EtNU/ g to IO-day-old SO IX rats. Initial values 
are those at J hr after the carcinogen pulse, normalized to 1.0 (Goth and 
Rajewsky J974a,b; L. Ya. Lomakina and M. F. Rajewsky. unpub!.). 
duced influx of cycling cells into the S phase. In principle, this could counter-
act the effect of a reduced elimination rate of 06-alkyJguanine [rom DNA, in 
tenns of the probability of anomalous base-pairing during ONA replication. 
However. as has been demonstrated recently in 8-day-old Wag rats by means 
of ['Hjthymidine labeling and autoradiography (Bosch and Ebels 1976), 
cells resume DNA synthesis at 36 hours in the subcpendymal layer of the 
brain, and at 12 hours in the trigeminal nerve, fonowing a pulse of 100 p.g 
of EtNU/g body weight. These delay periods are well below the half-life 
value for O' -EtG in brain DNA of the lO-day-old BO IX rat (- 229 hr; 
Table 2). 
As shown in Figure 3, OS-EtG was equally persistent in brain DNA of 
100day-old BO IX and BO IV rats. According to Oruckrey et a!. (1970a), 
the median time (T GO) until death with neuroectodennal neoplasms after a 
dose of 50 ~g of EtNU/ g on the 15th day of gestation was approximately 
three times longer (with a somewhat reduced tumor incidence) in BD IV 
than in BD IX rats. On the other ha!ld. no data are as yet available on the 
tumorigenicity of EtNU in 10-day-old BO IV rats and on the relative fre-
quencies of high-risk target cells present in the NS of 15th-day BO IV vs. 
BD IX fetuses. Nonetheless. comparative analyses in genetically defined 
718 M. F. R., .... ky elal. 
slrains with a differenlial response to EINU (Searle and Jones 1976) may 
provide important information on host factors influencing the process of 
carcinogenesis during the period following the initial carcinogen-target-cell 
interactions. 
It might be argued that the observed tissue differences in the elimination 
rates from DNA of O'·EtG could resull mainly from differenlial dilulion of 
Ihis promutagenic produci in DNA. due to dillerent rate, of DNA replication 
in the respective tissues. However, if this were the case, the elimination rates, 
for example. of N'-EIG from brain vs. liver DNA should differ by a factor 
similar to that found for the half-lives of o n-EtG, unless unexpected variations 
existed in these tissues regarding intranuclear conditions for hydrolysis of 
glycosidic linkages in DNA. Rather. the data argue slrongly for Ihe existence 
of a specific enzymatic mechanism for elimination of OG-alkyJguanine from 
DNA which is either lacking or substantially less effective in rat brain. Such 
a mechanism basically could operate analogously to the scheme of excision 
repair, involving (a) specific enzyme(s) for recognition and removal of the 
modified bases and (b) subsequent repair of the resulting apurinic sites. A 
mammalian enzyme selectively releasing OG-alkylguanine from DNA has thus 
far not been identified. However, recent data from several laboratories (Kirti· 
kar and Goldthwail 1974; Maher el al. 1974; Verly 1975; Laval 1976; 
Lindahl 1976) suggest Ihat this may soon be Ihe case. 
Seleclive persistence or O··methylguanine (O'-MeG) in the DNA of ral 
brain was also demonstrated recently when the predominantly NS-specific 
carcinogen MeNU was applied to young-adult BD IX rats over a period of 
35 days (Kleihues and Margison 1974; Margison and Kleihues 1975) . Since 
it is known that kidney tumors occasionally develop after single high doses 
of MeNU (Druckrey et al . 1967). it is of interest that a low degree of 
accumulation of OS-MeG also was seen in kidney DNA. Extending these 
analyses 10 Ihe dialkylnilrosamines. it was funher found (Nicoll et a1. 1975; 
Magee et a1. 1975) thai after a single high dose of 20 ~g of dimethylnitros-
amine (DMN) / g to adull rals (which induces tumors of the kidney but 
not of the liver [Swann and Magee 1968]) . O'-MeG is much more Slowly 
eliminated from kidney DNA than alter a low (non-kidney·tumorigenic) 
dose (2.5 ~g DMN/ g). More recenlly. Kleihues and Margison (1976) have 
found that the excision repair system for OS-MeG in rat liver apparently can 
be exhaUSled by sublelhal doses of MeNU and related alkylaling carcinogens 
and requires several days for recovery. 
DNA-Protein Interacllons 
Various investigators have pointed out that besides direct mutational effects 
on DNA, interference of carcinogens with molecular systems controlling gene 
transcription could lead equally to quasipennanent alterations in the readout 
of DNA (Pitot and Heidelberger 1963; Tsanev and Sendov 1971; Miller and 
Miller 1974; Heidelberger 1975). In Ihis contexi. Ihe inleractions of regula· 
tory chromosomal proteins (CP) with DNA require particular attention. 
Investigations regarding this point are still very much in their infancy. After 
a t.p. pulse of 75 ~g of EtNU/ g 10 Ihe 18lh-day BD IX rat fetus. the rate of 
[14C]leucine incorporation into histones F2al, F2a2, and F3 and into 13 in-
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dividual nonhistone CP of the brain (separated by electrophoresis in 15% and 
10% polyacrylamide gels) showed a biphasic response. with a common 
second maximum as late as 15 days after the EtNU pulse (Biessmann and 
Rajewsky 1975, 1976) . A first peak of nonhistone CP synthesis appeared at 
24 hours. i.e .• at a time when histone synthesis (and DNA synthesis; Goth 
and Rajewsky I 974b) had not yet recovered from an initial depression. 
Chromatin dissociation and reassociation experiments following incorporation 
of radioactive leucine into brain CP at 120 hours after a pulse of 75 p.g of 
EtNU/g to 10-day-old BD IX rats indicated an increased rate of CP synthesis 
and an increased affinity of the newly synthesized CP for brain DNA isolated 
from both control and EINU-treated BD IX rats (Augenlicht et al. 1975). 
The significance of these observations in relation to the process of carcino-
genesis by EtNU remains to be evaluated. 
Malignant Transformation of Fetal Rat Brain Cells In Culture 
after Exposure to EtNU In Vivo 
The above analyses on whole tissues do not provide information on the 
differentiative and proliferative properties of the particular (precursor) 
brain cells that undergo neoplastic transformation after exposure to EtNU. 
Furthennore. the interval between the initial carcinogen--cell interaction and 
the onset of clonal tumor growth represents an unclarified phase in the 
process of carcinogenesis. which may involve a sequence of characteristic 
phenotypic and functional alterations of the presumptive cancer cells. The 
obvious difficulties in analyzing these phenomena in intact tissues may be 
circumvented in part by the use of appropriate cell-culture systems. We 
have therefore developed an "in vivo-in vitro" system where the tissue-specific 
carcinogen EtNU is administered in vivo prior to transfer of the respective 
target cells "at risk" (Ietal BD IX rat brain cells, FBC) to long-term cell cul-
ture (Lacrum and Rajewsky 1975). This procedure combines several favor-
able features: (1) The target cells are exposed to the carcinogen under 
physiological conditions in vivo. (2) The sequence of events subsequently 
monitored in vitro occurs in a cell population derived from the very cell sys-
tem that would give risc to neuroectodermal tumors in vivo after an EtNU 
pulse at the perinatal age. (3) Fetal rat cells appear to undergo "spontaneous" 
neoplastic transformation in culture less frequently than embryonic cells 
lrom other rodent species (Sanlord 1967). (4) With the aid 01 different 
markers (Herschman et al. 1971; Eng et al. 1971; Wilson et al. 1972; 
Laerum et at. 1976. 1977a). the resulting neoplastic cell lines can be analyzed 
for the phenotypic expression of NS-specific properties. (5) Under stan-
dardized conditions, the system may become applicable for assaying the trans-
formation frequencies of preselected subpopulations of FBC. 
Dissociated FBC. transferred to long-term monolayer cen culture at 
20-90 hours alter a t.p. pulse of 75 ~g of EtNU/ g body weight on the 18th 
day of gestation. became tumorigenic after about 200 days (as assayed by 
rcimplantation into baby BD IX rats; Table 3) (Laerum and Rajewsky 
1975). This time interval is of the same order as the median time until death 
with neurocctodermal tumors (T ~ = 195 days; Table 1) in the offspring of 
BD IX rats injected with the same dose of EtNU at the same stage of gesta-
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Table 3 
Neoplastic Transformation of Fetal (l8th Day of 
Gestation) BD IX Rat Brain Cells in Culture after 
a t.p. Pulse of 7S ~g of EtNUI g In Vivo 
Time Passage 
intervQI Days number 
I y ' 98 (:t20) 4 ( :to.7) 
I.b 138 (:t19) 6 ( :t2) 
'T' 199 (:t28) 12 (:t2) 
Mean values ( :!: S.E. ) are given for seven inde· 
pendent sets of experiments. Cell suspensions from 
6-10 pooled fetal brains, corresponding to ~ IO 
separate primary monolayer cullures (1-2 X 108 
cells/ culture), were used per eltperiment. Untreated 
control cultures died oul afler 121 = 39 days (S.E. ) 
and ~4 culture passages. (Data from Laerum and 
Rajewsky 1975.) 
a TIme interval between EtNU pulse in vivo and 
first observation of morphological transformation. 
b Time interval between EtNU pulse in vivo and 
tint observation of colony formation in semisolid agar 
medium. Initial cloning efficiency for 10" viable ceUs/ 
30 mt O. IS% agar medium, 0.9 ::!: 0.3% (S.E.). 
e Time interval between EtNU pulse in vivo and 
fi rst o bservation of tumorigenicity in isogeoic hosts. 
The average time interval from subcutaneous (s.c. ) 
reimplantation of lOS cells ioto baby BO IX rats until 
the first tumors became palpable was 48 = 13 days 
(5.E. ) . Occasionally, much longer latency intervals 
( ::= 10 months) were recorded. 
tion (Goth and Rajewsky 1974b; Laerum and Rajewsky 1975). Acquisition 
of tumorigenicity in culture was preceded by a sequence of characteristic 
phenotypic changes, termcd "stages I-V" (Fig. 5; Table 3). During stage I 
(early primary culture) , both EtNU and untreated control cultures con~ 
tained stationary glia~like cells on a growing layer of fiat , epithelioid cells 
(possibly glial precursors) and a few fibroblastoid cells. Stage II (-I Oth-
40th day) was characterized by a constant proportion of glia-like cells in the 
EtNU cultures and their gradual disappearance in the controls. During stage 
III (-40th- IOOth day), slowly promerating glia-like cells in the EtNU 
cultures formed piled-up "nodules" which could be removed and cultured 
separately. The transition to stage IV (-IOOth-200th day) was marked by 
proliferation of "morphologically transformed" cells (enlarged cell bodies; 
reduced length and number per cell of cytoplasmic processes) . These formed 
colonies in semisolid agar and finally became tumorigenic, as assayed by sub-
cutaneous (s.c.) reimplantation into baby BD IX rats (stage V; see Table 3 
for average time intervals between different stages) . 
The neoplastic neurogenic cell-culture lines (BT lines) developed in this 
in viv~in vitro system have been analyzed with regard to some of their 
phenotypic properties (Laerum et al. I 977b). Like several neurogenic 
cell-culture lines (V lines) derived from EtNU~induced . neuroectodermal 
BD IX rat tumors (Laerum and Rajewsky 1975), the BT lines contained 
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Diagrammatic representation of the in vivo-in vitro system Cor neoplastic trans-
formation of fetal BO IX rat brain cells in culture, after t.p. exposure to EtNU in 
vivo. eNS indicates central nervous system; PNS indicates peripheral nervous 
system. (Reprinted, with pennission, from Laerum and Rajewsky 1975.) 
multipolar, glia-like cells, but also flatter cells with shorter and fewer cyto-
plasmic processes, and occasionally giant cells. As would be expected, the 
multiclonal "parental" BT and V lines contained multiple subpopulations 
of cells with different degrees of aneuploidy (Hanke and Rajewsky 1975; 
Laerum and Hansteen 1975). n.is was also reflected by plurimodal DNA 
distributions recorded by pulse-cytophotometry (Lacrum and Hansteen 
1975; Hanke and Rajewsky 1975; Rajewsky et al. 1976). As assayed by 
indirect immune fluorescence, all parental lines and their (cloned) sublines 
(total number > 30) contained the N5-specific marker protein 5-100, but 
to a varying degree and in varying proportions of cells (Laerum and Rajew-
sky 1975; Laerum et al. 1977b). This predominantly glia-specific protein is 
not yet expressed in FBC (Herschman et a1. 1971). There was no indication 
of more than borderline neurotransmitter activity (acetylcholinesterase, 
choline acetyltransferase, L-glutamate decarboxylase). nor has electrical mem-
brane excitability been detected (Laerum et al. 1976). Serologic analyses by 
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the Ouchterlony test of selected BT and V lines gave no evidence for the 
presence of group-specific (gs) interspecies oncomaviral antigens (Schafer et 
a!. 1973; by courtesy of Prof. W. ScMfer, Max-Planck-Institut fUr Virusfor-
schung, Ttibingen. Germany). 
The solid, transplantable tumors developed upon s.c. reimplantation of 
the parental BT lines appeared histologically as neurinoma-, glioma-. or 
glioblastoma-like and frequently pleiomorphic neoplasms. Although exhibiting 
a more atypical ceUular morphology, they grossly resembled the different 
types of neuroectodermal rat neoplasms induced by EtNU in vivo (Wechsler 
et a!. 1969). 
The present in vivo-in vitro system has not yet permitted subpopulations 
of probable high-risk FBC to be defined. However, the glia-Iike morphology 
of the particular cells that underwent morphological transformation and the 
demonstration, in the resulting neoplastic cell lines, of the predominantly 
glial 5-100 marker protein (with the lack of evidence for expression of 
neuronal properties) (Laerum and Rajewsky 1975; Laerum et al. 1976) 
make proliferative glial precursors potential candidates (Goth and Rajewsky 
1974a,b; Laerum and Rajewsky 1975). This would be in accordance with 
the assumption that the risk of neoplastic conversion may vary with the 
stage of the target cells in their differentiative pathway (from the stem 
cell to the mature, nonproliferative "end--cell") at the time of interaction 
with a carcinogen (Rajewsky 1972; Goth and Rajewsky 1974a,b; Laerum 
and Rajewsky 1975; Cairns 1975; Rajewsky et a!. 1976). 
It should be noted, however, that neuroglia and neurons are believed to 
have common neuroepithelial precursors (see Langman et a!. 1971). Im-
mature cells of neuronal lineages were certainly not absent from the present 
FBe cultures initially. Therefore, neoplastic clones expressing glial and/or 
neuronal properties might, in principle, have been expected to develop. How-
ever, during rat brain development and on an overall scale, the neuronal sys-
tem precedes the glial cell populations with respect to proliferation and 
maturation (see Altman 1969). Hence, at the developmental stage of the NS 
chosen for the EtNU pulse (18th day of gestation), the precursor compart-
ments may contain predominantly glial precursors. This in tum might explain 
the prevalence of neoplastic cells with glial phenotypic traits. Interestingly, 
some neoplastic cell lines also expressing neuron-like properties have recently 
been derived from neuroectodermal BD IX rat tumors induced by application 
of EtNU on the 15th day of gestation (Schubert et al. 1974). 
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